Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04923126Phase 1/2Recruiting
SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Low-Grade GliomaProgressive Low-Grade GliomaRecurrent Low-Grade Glioma
PrincipalinvestigatorStart date: 2021-06-21

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

St. Jude Children's Research Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Giles W. Robinson, MD

St. Jude Children's Research Hospital

Moderately Similar
4 trials

Shared therapeutic areas:

Low-grade GliomaProgressive Low-Grade GliomaRecurrent Low-Grade Glioma

Worked with same sponsors:

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanySt. Jude Children's Research Hospital
Collaborated on 1 trial
Similarity Score34%

Greg J Stanisz, PhD

Sunnybrook Health Sciences Centre

Related
1 trials

Shared therapeutic areas:

Low-grade Glioma
Similarity Score10%

Sébastien Perreault, MD

St. Justine's Hospital

Related
1 trials

Shared therapeutic areas:

Low-grade Glioma
Similarity Score10%

Timothy S Sannes, PhD

Dana-Farber Cancer Institute

Related
1 trials

Shared therapeutic areas:

Low-grade Glioma
Similarity Score10%

Jennie Taylor, MD, MPH

University of California, San Francisco

Related
1 trials

Shared therapeutic areas:

Low-grade Glioma
Similarity Score10%

Eugene Hwang, MD

Children's National Research Institute

Related
3 trials

Shared therapeutic areas:

Low-grade Glioma
Similarity Score10%

Martin Van den Bent

EORTC Study Coordinator

Related
1 trials

Shared therapeutic areas:

Low-grade Glioma
Similarity Score10%

Marc Vooijs, Prof. Dr.

Maastro Radiaton Oncology clinic

Related
1 trials

Shared therapeutic areas:

Low-grade Glioma
Similarity Score10%

Nicolas MENJOT DE CHAMPFLEUR, MD, PhD

University Hospital, Montpellier

Related
1 trials

Shared therapeutic areas:

Low-grade Glioma
Similarity Score10%

Juliette Southworth, BS, CCRP

University of Alabama at Birmingham, NFCTC

Related
1 trials

Shared therapeutic areas:

Low-grade Glioma
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04923126Phase 1/2PrincipalInvestigator

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

Low-Grade GliomaProgressive Low-Grade GliomaRecurrent Low-Grade Glioma
Recruiting

All 1 trials loaded